Does AMPICILLIN\SULBACTAM Cause Off label use? 124 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 124 reports of Off label use have been filed in association with AMPICILLIN\SULBACTAM. This represents 7.5% of all adverse event reports for AMPICILLIN\SULBACTAM.
124
Reports of Off label use with AMPICILLIN\SULBACTAM
7.5%
of all AMPICILLIN\SULBACTAM reports
35
Deaths
61
Hospitalizations
How Dangerous Is Off label use From AMPICILLIN\SULBACTAM?
Of the 124 reports, 35 (28.2%) resulted in death, 61 (49.2%) required hospitalization, and 17 (13.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMPICILLIN\SULBACTAM. However, 124 reports have been filed with the FAERS database.
What Other Side Effects Does AMPICILLIN\SULBACTAM Cause?
Drug ineffective (258)
Pyrexia (98)
Rash (98)
Diarrhoea (93)
Condition aggravated (83)
Drug hypersensitivity (70)
Pneumonia (68)
Acute kidney injury (66)
Drug eruption (66)
Pruritus (54)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which AMPICILLIN\SULBACTAM Alternatives Have Lower Off label use Risk?
AMPICILLIN\SULBACTAM vs AMPRENAVIR
AMPICILLIN\SULBACTAM vs AMPYRA
AMPICILLIN\SULBACTAM vs AMRUBICIN
AMPICILLIN\SULBACTAM vs AMSACRINE
AMPICILLIN\SULBACTAM vs ANAGRELIDE